Q1 2020 Earnings Supplemental Materials

May 4, 2020

Forward-Looking Statements

This presentation contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements, which express management's current views concerning the future of our business, future plans and strategies, projections, outlook, anticipated cost savings, anticipated synergies, other anticipated events and trends, the economy and other future conditions, appear throughout this presentation. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management's current beliefs, expectations and assumptions. Because forward-looking statements relate to the future, they are difficult to predict and many are largely or partially outside of our control. Important factors that could cause our actual results and financial condition to differ materially from those indicated in forward-looking statements include those discussed under the caption "Risk Factors" in the prospectus we filed with the U.S. Securities and Exchange Commission ("SEC") on February 7, 2020, those discussed under the caption "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2019 that we will file with the SEC, and similar factors discussed in our other filings with the SEC. However, those factors should not be considered to be a complete statement of all potential risks and uncertainties. Forward-looking statements are based only on information currently available to our management and speak only as of the date of this presentation. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. Please consult our public filings with the SEC and our website at www.clarivate.com.

Non-GAAP Financial Measures

This presentation contains financial measures which have not been calculated in accordance with United States generally accepted accounting principles ("GAAP"), including Adjusted Revenues, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, Adjusted Free Cash Flow and Standalone Adjusted EBITDA, because they are a basis upon which our management assesses our performance and we believe they reflect the underlying trends and indicators of our business. Although we believe these measures may be useful for investors for the same reasons, these financial measures should not be considered as an alternative to GAAP financial measures as a measure of the Company's financial condition, profitability and performance or liquidity. In addition, these financial measures may not be comparable to similar measures used by other companies. At the Appendix to this presentation, we provide further descriptions of these non-GAAP measures and reconciliations of these non-GAAP measures to the corresponding most closely related GAAP measures.

Required Reported Data

We are required to report Standalone Adjusted EBITDA, which is identical to Consolidated EBITDA and EBITDA as such terms are defined under our credit agreement, and the indenture governing our senior secured notes due 2026, respectively, pursuant to the reporting covenants contained in such agreements. In addition, management of the Company uses Standalone Adjusted EBITDA to assess compliance with various incurrence-based covenants in these agreements.

2

Q1 Highlights

Well-positioned business model to weather current environment

Enhanced

Product

Portfolio

Efficiently

Managing

Business

  • Completed acquisition of Decision Resources Group ("DRG"); initiated integration activities
  • Completed integration of Darts-ip within the CompuMark product suite
  • Completed divestiture of brand protection, anti piracy and anti fraud products
  • Science Group: Launched Cortellis Drug Discovery Intelligence, released Cortellis Generics Intelligence, the new version of Newport
  • IP Group: Launched improved Derwent Patents database platform, SequenceBase functionality integrated into Derwent
  • Meeting or exceeding productivity and service level agreements despite COVID-19 customer workflow disruptions
  • Implemented $30 million of cost savings initiatives to offset potential effects of COVID-19
  • Delivering savings from existing $70-$75 million cost savings program; $45 million in 2020
  • Capturing DRG cost synergies of $10 million in 2020
  • Repaid $65 million outstanding revolver balance
  • Significant resources of $308 million cash and untapped revolver of $250 million to re- invest in growth

3

Q1 Results

Revenue growth driven by acquisitions, new business and pricing; excluding divestitures

adjusted revenue increased 11%(1)

Reported Revenue

Adjusted Revenue(1)

Adjusted EBITDA(1)

+3% actual f/x

+4% actual f/x

Adjusted EBITDA

+4% constant f/x

+4% constant f/x

Margin(2) 32.2% up

690 basis points

$243

$234

$241

$234

$78

$42

Transactional

$49

$59

+32%

+18%

$193

Subscription

$193

+slightly

Q1'19

Q1'20

Q1'19

Q1'20

Q1'19

Q1'20

($ in millions, actual f/x)

Excluding Divested Products at Constant F/X(3)

Adjusted revenue(1) actual f/x

+10%

Adjusted revenue(1) constant f/x

+11%

Adjusted subscription revenue(1)

8%

Adjusted transactional revenue(1)

21%

  1. See the Appendix for a reconciliation of GAAP to Non-GAAP measures.
  2. Adjusted EBITDA Margin equals Adjusted EBITDA divided by Adjusted Revenue. See the Appendix for a reconciliation of GAAP to Non-GAAP measures.

(3) In November 2019, Clarivate announced an agreement to sell the MarkMonitor brand protection, antipiracy and antifraud products, and completed such divestiture

4

on January 1, 2020. Clarivate retained the MarkMonitor Domain Management business.

Q1 Financial Highlights…

Solid topline growth and cost efficiencies drove double-digit Adjusted EBITDA growth and

significant margin expansion

March 31,

($ in millions except per share data)

2020

2019

%

Excluding

Organic(2)

Change

Divestitures

Adj. Subscription revenue(1)

$193

$193

Up

8%

3%

slightly

Adj. Transactional revenue(1)

49

42

18.1%

21%

(3%)

Commentary

Recent acquisitions, new business and price increases, offset by divestitures and delay in a few contracts being renewed in Q1 '20 due to customer temporary workflow disruptions and expected to be renewed during Q2 '20

Recent acquisitions, increase from Techstreet products, partially offset by divested businesses, decrease in backfile sales and lower CompuMarkTM search volumes

Adj. total revenues, net(1)

243

234

3.5%

11%

Annual Contract Value ("ACV")

820

765

7.2%

15%

Adjusted EBITDA(1)

78

59

32.1%

---

Adjusted EBITDA margin(1)

32%

25%

690bps

---

Other income/expense, net

6

(6)

207.4%

---

Provision for income taxes

15

(0)

---

---

2%

3% Addition of DRG offset by higher open renewals

  • Revenue growth, acquisitions, portfolio rationalization and benefit of cost savings initiatives
  • Strong revenue flow-through
  • Primarily related to a gain in foreign currency exchange in Q1 '20 while prior year included foreign currency losses
    Timing issue including addition of DRG tax provision, increases in
  • taxable income and respective tax expense over the prior 12- month period

Cash taxes

$5

$8

(38.5%)

---

--- Q1 '19 higher due to tax payment timing differences

Adjusted net income(1)

$26

N/A

---

---

---

Timing of higher tax provision reduced strong operating results

Adjusted diluted EPS(1)

$0.07

N/A

---

---

---

Impacted higher tax provision, increase in weighted diluted shares

36.8 million shares or 11% since Dec. 2019

(1)

See the Appendix for a reconciliation of GAAP to Non-GAAP measures.

5

(2)

At constant currency.

…Q1 Financial Highlights Continued

Significant resources including $308 million in cash and untapped $250 million revolver to

continue to invest in strategic growth opportunities

($ in millions)

March 31,

December 31,

$

Commentary on Change

2020

2019

Change

Cash and cash equivalents

$308

$76

$232

Proceeds of $277.5 million received from the voluntary exercise of 24.1 million

warrants in exchange for ordinary shares of Clarivate

Total debt outstanding

$1,957

$1,665

$292

Net debt

$1,649

$1,589

$60

Gross leverage ratio(1)

4.6

5.0x

Net leverage ratio(1)

3.9x

4.7x

$360.0 million incurred to fund a portion of the DRG acquisition offset by a $65 million repayment of the revolver in full

March calculation includes proforma adjusted EBITDA for last twelve months for the acquisition of DRG completed end of Feb.2020

Decline in leverage ratio due to increase in cash and higher standalone adjusted

EBITDA

March 31, 2020 March 31, 2019

Capital expenditures

$19

$6

$13

Cash flow from operations

$46

$43

$3

Free cash flow

$27

$37

($10)

Adjusted free cash flow(1)

$78

$64

$14

Application development investment across product portfolio, one-time purchase of hardware in preparation for change to work from home

Higher capital expenditures in Q1 '20

Primarily due to zero cash payments to Thomson Reuters for Transition Services Agreement in Q1 '20 as the agreement was completed six months ahead of schedule

(1) See the Appendix for a reconciliation of GAAP to Non-GAAP measures.

6

Efficiently Managing Cost Structure and Freeing up Resources

Approximately $110 million in permanent cost reductions

($ in millions) Total Savings Permanent SavingsTiming

NEW

$30M

$5 million

Q1-Q4 2020

COVID related

Cost savings 2019

$70-$75 million

$70-$75 million

$45 million in 2020; $70-75

million run-rate exiting Q1 2021

DRG synergies(1)

$10 million in 2020; $30 million

$30 million

$30 million

run-rate within 18 months of

close

Total Cost Savings

$130-$135 million

$105-$110 million

(1) Decision Resources Group ("DRG") acquisition completed February 28, 2020.

7

2020 Outlook Assumptions

Business Model to Weather Current

Environment

  • "Must-have"products and services focused on B2B markets with unique content
  • Sell into durable end markets including government, research institutions and life sciences
  • Solutions to clients on digital basis and consumed anywhere
  • Highly resilient with 80% recurring / re- occurring revenue streams
  • Strong revenue retention rates
  • Low levels of capital intensity and cash taxes

Outlook Assumptions

  • Virus brought under control late Q2 2020
  • Gradual lifting of restrictions / free movement of labor mid-to-late Q3 2020
  • Recovery starting early Q4 2020

8

Updated 2020 Outlook

Potential revenue downside offset by tiered cost reduction approach leading to no change

to Adjusted EBITDA, Adjusted EPS, Adjusted Free Cash Flow

($ in millions, except per share information)

Prior Outlook

Updated Outlook

Low

High

Low

High

Adjusted Revenue

$1,160

$1,190

$1,130

$1,160

Adjusted EBITDA

$395

$420

No Change

No Change

Adjusted EBITDA margin %

34%

35%

35%

36%

Adjusted Diluted EPS(1)

$0.53

$0.59

No Change

No Change

Adjusted Free Cash Flow

$220

$240

No Change

No Change

Our target is to exit 2021 with 6% - 8% organic revenue growth and adjusted

EBITDA margin of 37% - 40%

See Appendix for reconciliation of GAAP to Non-GAAP measures.

  1. Adjusted diluted EPS for 2020 is calculated based on approximately 381.9 million fully diluted weighted average shares outstanding, an increase of approximately 52.1 million shares or 16%, compared to 329.8 million shares outstanding at the end of December 31, 2019. The increase in shares is primarily driven by the February 2020 offering of 27.6 million shares,

with proceeds used to fund a portion of the cash consideration for the acquisition of Decision Resources Group, and the issuance of approximately 29 million ordinary shares upon

9

exercise of outstanding warrants.

Historical Annualized Contract Value (ACV)(1)

($ in millions)

  • Q1 '20 includes the acquisition of Decision Resources Group ("DRG") completed on February 28, 2020
  • All periods exclude divested products at actual F/X; divested on January 1, 2020

$820

+ $104 mm YoY

+ 15% constant f/x

Ongoing ACV +3%

$736 $744 $750

$706 $710 $718 $716

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

(1) Annualized Contract Value refers to the annualized value for a 12-month period following a given date of all subscription-based client license agreements, assuming that all

10

license agreements that come up for renewal during that period are renewed.

Appendix

11

Presentation of Certain Non-GAAP Financial Measures

This presentation contains financial measures which have not been calculated in accordance with GAAP, including Adjusted Revenues and Adjusted EBITDA, because they are a basis upon which our management assesses our performance and we believe they reflect the underlining trends and indicators of our business.

Adjusted Revenues

Adjusted Revenues excludes the impact of the deferred revenues purchase accounting adjustment (primarily recorded in connection with recent acquisitions).

Our presentation of Adjusted Revenues is presented for informational purposes only and is not necessarily indicative of our future results. You should compensate for these limitations by relying primarily on our GAAP results and only using Adjusted Revenues for supplementary analysis.

Adjusted EBITDA

Adjusted EBITDA is calculated using net (loss) income before provision for income taxes, depreciation and amortization and interest income and expense adjusted to exclude acquisition or disposal-related transaction costs (such costs include net income from continuing operations before provision for income taxes, depreciation and amortization and interest income),stock-based compensation, unrealized foreign currency gains/(losses), transition services agreement costs entered into with Thomson Reuters in 2016 ("Transition Services Agreement"), separation and integration costs, transformational and restructuring expenses, acquisition-related adjustments to deferred revenues, non-cash income/(loss) on equity and cost method investments, non-operating income or expense, the impact of certain non-cash and other items that are included in net income for the period that the Company does not consider indicative of its ongoing operating performance, and certain unusual items impacting results in a particular period.

In future periods, the Company will need to make additional capital expenditures in order to replicate capital expenditures associated with previously shared services on a stand-alone basis. You are encouraged to evaluate these adjustments and the reasons the Company considers them appropriate for supplemental analysis. These measures are not measurements of the Company's financial performance under GAAP and should not be considered in isolation or as alternatives to net income, net cash flows provided by operating activities, total net cash flows or any other performance measures derived in accordance with GAAP or as alternatives to net cash flows from operating activities or total net cash flows as measures of the Company's liquidity.

Reduction of ongoing standalone and Transition Services Agreement costs have been, and are expected to continue to be, a component of the Company's strategy as it finalizes its transition to a standalone company following the 2016 Transaction.

Certain of the adjustments included to arrive at Adjusted EBITDA are related to the Company's transition to an independent company. In evaluating Adjusted EBITDA you should be aware that in the future the Company may incur expenses that are the same as or similar to some of the included adjustments. The Company's presentation of Adjusted EBITDA should not be construed as an inference that the Company's future results will be unaffected by any of the adjusted items, or that the Company's projections and estimates will be realized in their entirety or at all.

12

Presentation of Certain Non-GAAP Financial Measures

The use of Adjusted EBITDA instead of GAAP measures has limitations as an analytical tool, and you should not consider Adjusted EBITDA in isolation, or as a substitute for analysis of the Company's results of operations and operating cash flows as reported under GAAP. For example, Adjusted EBITDA does not reflect:

  • the Company's cash expenditures or future requirements for capital expenditures
  • changes in, or cash requirements for, the Company's working capital needs
  • interest expense, or the cash requirements necessary to service interest or principal payments, on the Company's debt
  • any cash income taxes that the Company may be required to pay
  • any cash requirements for replacements of assets that are depreciated or amortized over their estimated useful lives and may have to be replaced in the future
  • all non-cash income or expense items that are reflected in the Company's statements of cash flows

The Company's definition of and method of calculating Adjusted EBITDA may vary from the definitions and methods used by other companies when calculating adjusted EBITDA, which may limit their usefulness as comparative measures.

The Company prepared the information included in this presentation based upon available information and assumptions and estimates that it believes are reasonable. The Company cannot assure you that its estimates and assumptions will prove to be accurate.

Because the Company incurred transaction, transition, integration, transformation, restructuring, and Transition Services Agreement costs in connection with the 2016 Transaction and the transition, borrowed money in order to finance its operations, and used capital and intangible assets in its business, and because the payment of income taxes is necessary if the Company generates taxable income after the utilization of its net operating loss carryforwards, any measure that excludes these items has material limitations. As a result of these limitations, these measures should not be considered as a measure of discretionary cash available to the Company to invest in the growth of its business or as a measure of its liquidity.

Adjusted EBITDA Margin

Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Adjusted Revenues.

13

Presentation of Certain Non-GAAP Financial Measures

Adjusted Net Income and Adjusted Diluted EPS

We have begun to use Adjusted Net Income and Adjusted Diluted Earnings Per Share ("Adjusted Diluted EPS") in our analysis of the financial performance of the Company. We believe Adjusted Net Income and Adjusted Diluted EPS are meaningful measures of the performance of the Company because they adjust for items that do not directly affect our ongoing operating performance in the period.

Adjusted Net Income is calculated using net income (loss), adjusted to exclude acquisition or disposal-related transaction costs (such costs include net income from continuing operations before provision for income taxes, depreciation and amortization and interest income and expense from the divested business), amortization related to acquired intangible assets, stock-based compensation, unrealized foreign currency gains/(losses), Transition Services Agreement costs, separation and integration costs, transformational and restructuring expenses, acquisition-related adjustments to deferred revenues, non-cash income (loss) on equity and cost method investments, non-operating income or expense, the impact of certain non-cash and other items that are included in net income for the period that the Company does not consider indicative of its ongoing operating performance, certain unusual items impacting results in a particular period, and the income tax impact of any adjustments. We calculate Adjusted Diluted EPS by using Adjusted Net Income divided by diluted weighted average shares for the period.

Standalone Adjusted EBITDA

We are required to report Standalone Adjusted EBITDA pursuant to the reporting covenants contained in the Credit Agreement and the Indenture. Standalone Adjusted EBITDA is substantially similar to Consolidated EBITDA and EBITDA as such terms are defined under the Credit Agreement and the Indenture, respectively. In addition, the Credit Agreement and the Indenture contain certain restrictive covenants that govern debt incurrence and the making of restricted payments, among other matters. These restrictive covenants utilize Standalone Adjusted EBITDA as a primary component of the compliance metric governing our ability to undertake certain actions otherwise proscribed by such covenants. Standalone Adjusted EBITDA reflects further adjustments to Adjusted EBITDA for cost savings already implemented and excess standalone costs.

Because Standalone Adjusted EBITDA is required pursuant to the terms of the reporting covenants under the Credit Agreement and the Indenture and because this metric is relevant to lenders and noteholders, management considers Standalone Adjusted EBITDA to be relevant to the operation of its business. It is also utilized by management and the compensation committee of the Board as an input for determining incentive payments to employees.

Excess standalone costs are the difference between our actual standalone company infrastructure costs, and our estimated steady state standalone infrastructure costs. We make an adjustment for the difference because we have had to incur costs under the Transition Services Agreement after we had implemented the infrastructure to replace the services provided pursuant to the Transition Services Agreement, after we had implemented the infrastructure to replace the services provided pursuant to the Transition Services Agreement, thereby incurring dual running costs. Furthermore, there has been a ramp up period for establishing and optimizing the necessary standalone infrastructure. Since our separation from Thomson Reuters, we have had to transition quickly to replace services provided under the Transition Services Agreement, with optimization of the relevant standalone functions typically following thereafter. Cost savings reflect the annualized "run rate" expected cost savings, net of actual cost savings realized, related to restructuring and other cost savings initiatives undertaken during the relevant period.

Standalone Adjusted EBITDA is calculated under the Credit Agreement and the Indenture by using our Net Income for the trailing twelve month period (defined in the Credit Agreement and the Indenture as our GAAP net income adjusted for certain items specified in the Credit Agreement and the Indenture) adjusted for items including: taxes, interest expense, depreciation and amortization, non-cash charges, expenses related to capital markets transactions, acquisitions and dispositions, restructuring and business optimization charges and expenses, consulting and advisory fees, run-rate cost savings to be realized as a result of actions taken or to be taken in connection with an acquisition, disposition, restructuring or cost savings or similar initiatives, "run rate" expected cost savings, operating expense reductions, restructuring charges and expenses and synergies related to the transition following the separation of the Company's business from Thomson Reuters (the "2016 Transaction") projected by us, costs related to any management or equity stock plan, other adjustments that were presented in the offering memorandum used in connection with the issuance of the Notes and earnout obligations incurred in connection with an acquisition or investment.

14

Presentation of Certain Non-GAAP Financial Measures

Free Cash Flow and Adjusted Free Cash Flow

We use free cash flow and adjusted free cash flow in our operational and financial decision-making and believe free cash flow and adjusted free cash is useful to investors because similar measures are frequently used by securities analysts, investors, ratings agencies and other interested parties to evaluate our competitors and to measure the ability of companies to service their debt. Free cash flow is calculated using net cash provided by operating activities less capital expenditures. Adjusted free cash flow is calculated as free cash flow, less cash paid for transition services agreement, transition, transformation and integration expenses, transaction related costs and debt issuance costs offset by cash received for hedge accounting transactions. The following table reconciles our non-GAAP free cash flow measure to net cash provided by operating activities:

15

Quarterly Financial Summary

($ in millions)

Q2 2018

Q3 2018

Q4 2018

Q1 2019

Q2 2019

Q3 2019

Q4 2019

Q1 2020

Revenues, net

$243.3

$242.9

$245.2

$234.0

$242.3

$243.0

$255.0

$240.6

Deferred revenue adjustment

$0.9

$0.5

$0.2

$0.2

$0.1

$0.1

$0.1

$1.9

IPM Product Line

($5.8)

($7.8)

$ -

$ -

$ -

$ -

$ -

$ -

Adjusted Revenue(1)

$238.4

$235.6

$245.5

$234.2

$242.4

$243.1

$255.1

$242.5

Subscription revenues

$199.5

$204.3

$197.6

$192.5

$202.7

$200.8

$209.5

$193.2

IPM Product Line

($4.8)

($6.8)

$-

$ -

$ -

$ -

$ -

$ -

Adj. Subscription Revenue(1)

$194.7

$197.5

$197.6

$192.5

$202.7

$200.8

$209.5

$193.2

Transactional revenues

$44.7

$39.1

$47.8

$41.7

$39.7

$42.3

$45.6

$49.2

IPM Product Line

($1.0)

($1.0)

$-

$ -

$ -

$ -

$ -

$ -

Adj. Transactional Revenue(1)

$43.7

$38.1

$47.8

$41.7

$39.7

$42.3

$45.6

$49.2

Adjusted EBITDA(2)

$67.5

$66.3

$75.8

$59.2

$73.2

$77.0

$84.6

$78.2

Adjusted EBITDA margin %(2)

28.3%

28.1%

30.9%

25.3%

30.2%

31.7%

33.2%

32.2%

1.

Adjusted Revenue excludes the divested IPM business revenues for the period, and adds back the deferred revenue purchase accounting adjustment.

16

2.

See the Appendix for a reconciliation of GAAP to non-GAAP financial measures.

Diluted Share Count 9

Enterprise Value Build

@$20

@$21

@$22

@$23

@$24

@$25

(Forecasted as of and for the year ended

December 31, 2020, $ in millions except for per

share values)

Share Price

Ticker

1

Current Share (Live)

$

20.00

$

21.00

$

22.00

$

23.00

$

24.00

$

25.00

Enterprise Value Build

Basic Shares Outstanding

365,981,718

365,981,718

365,981,718

365,981,718

365,981,718

365,981,718

2

(+) Stock Dilution

17,464,566

18,533,473

19,505,521

20,396,502

21,218,103

21,978,104

Forecasted Fully Diluted Shares Outstanding

383,446,284

384,515,191

385,487,239

386,378,220

387,199,821

387,959,822

(x) Share Price

$

20.00

$

21.00

$

22.00

$

23.00

$

24.00

$

25.00

Equity Value ($ in millions)

7,668.9

8,074.8

8,480.7

8,886.7

9,292.8

9,699.0

3

(+) Debt ($ in millions)

1,928.1

1,928.1

1,928.1

1,928.1

1,928.1

1,928.1

(-) Cash ($ in millions)

310.9

310.9

310.9

310.9

310.9

310.9

3

Enterprise Value ($ in millions)

9,286.1

9,692.0

10,097.9

10,503.9

10,910.0

11,316.2

Stock Options

4

Shares Contributing to Dilution

13,623,620

13,623,620

13,726,419

13,775,969

13,930,151

13,930,151

Weighted-average Exercise Price

Various

Various

Various

Various

Various

Various

4

Options Dilution

4,976,053

5,387,842

5,762,511

6,108,059

6,429,679

6,729,698

4

Public Warrants Outstanding

-

-

-

-

-

-

5

Warrants Contributing to Dilution

4,363,896

4,363,896

4,363,896

4,363,896

4,363,896

4,363,896

Weighted-average Exercise Price

$

11.50

$

11.50

$

11.50

$

11.50

$

11.50

$

11.50

Public Warrants Dilution

1,854,656

1,974,143

2,082,769

2,181,948

2,272,863

2,356,504

Private Warrants Outstanding

18,300,000

18,300,000

18,300,000

18,300,000

18,300,000

18,300,000

Exercisable as of December 31, 2020

18,300,000

18,300,000

18,300,000

18,300,000

18,300,000

18,300,000

Weighted-average Exercise Price

$

11.50

$

11.50

$

11.50

$

11.50

$

11.50

$

11.50

Private Warrants Dilution

7,777,500

8,278,571

8,734,091

9,150,000

9,531,250

9,882,000

RSUs Outstanding - 2019 Issued and 2020 Foreca

1,528,363

1,528,363

1,528,363

1,528,363

1,528,363

1,528,363

6

Weighted-average Exercise Price

-

-

-

-

-

-

RSU Dilution

419,591

456,150

489,384

519,729

547,545

573,136

PSUs - 2020 Forecast

-

-

-

-

-

-

7

Weighted-average Exercise Price

-

-

-

-

-

-

PSU Dilution

-

-

-

-

-

-

DRG Contingent Consideration

2,436,766

2,436,766

2,436,766

2,436,766

2,436,766

2,436,766

8

Weighted-average Exercise Price

-

-

-

-

-

-

DRG Contingent Consideration Dilution

2,436,766

2,436,766

2,436,766

2,436,766

2,436,766

2,436,766

Total Stock Dilution

17,464,566

18,533,473

19,505,521

20,396,502

21,218,103

21,978,104

Comments

Note: the analysis is not intended to replace the Treasury Stock Method as required under ASC 260, Earnings per Share

  1. Inconsistent with the requirements of ASC 260, but for illustrative purposes, this analysis uses hypothetical shares prices and not the actual average share price for the period as required under US GAAP.
  2. Includes the impact of the Merger Shares subsequent to the lifting of the performance vesting conditions as described in the Company's F-1 filed 2/3/20.
  3. Debt and cash amounts reflect 3/31/20 balances.
  4. Per the requirements of the Treasury Stock Method this excludes all management options that are antidilutive at the assumed share prices in this analysis and includes consideration of unrecognized compensation cost on unvested options.
  5. All public warrants have been redeemed as of March 31, 2020.
  6. Consists of actual 2019 and 2020, as well as forecasted 2020 RSUs and their related activity. This includes 0.3M issued RSUs for the year ended December 31, 2019, as well as forecasted issuances of 2.4M RSUs in 2020.
  7. Consistent with the requirements of ASC 260, performance conditions for the 0.5M PSUs granted in 2020 have not been achieved as of this time, and therefore are excluded from this dilution analysis.
  8. Consistent with the requirement of ASC 260, the impact of 2.9M estimated shares to be issued on the one year anniversary of acquisition of DRG (February 28, 2021) is included within this dilution analysis. Amount shown is the weighted average of the shares estimated to be issued based on the closing of the DRG transaction on February 28, 2020.
  9. The analysis assumes no share buy backs by the company during the period

17

Thank You

18

Reconciliation of Non-GAAP Financial Measures and Required Reported Data

The following tables present the amounts of our subscription and transactional revenues, including as a percentage of our total revenues, for the periods indicated, as well the drivers of the variances between periods.

Variance Increase/(Decrease)

Percentage of Factors Increase/(Decrease)

Total

Three Months Ended

Variance

Total Variance

Ongoing

March 31,

(Dollars)

(Percentage)

Acquisitive

Disposal

FX Impact

Business

(in millions, except percentages)

2020

2019

Subscription revenues

193.2

192.5

$

0.7

0.4 %

5.1 %

(7.3

)%

(0.7

)%

3.3

%

Transactional revenues

49.2

41.7

7.5

18.1 %

23.0 %

(1.6

)%

(0.8

)%

(2.5

)%

1

Deferred revenues adjustment

(1.9)

(0.2)

1.7

NM

NM

-

%

-

%

68.3

%

Revenues, net

$

240.6

$

234.0

$

6.6

2.8 %

7.5 %

(6.3 )%

(0.7

)%

2.3

%

1

Deferred revenues adjustment

$

1.9

$

0.2

1.7

NM

NM

-

%

-

%

68.3

%

Adjusted revenues, net

$

242.5

$

234.2

$

8.3

3.5 %

8.3 %

(6.3 )%

(0.7

)%

2.2

%

1. Reflects the deferred revenues adjustment made as a result of purchase accounting.

19

Reconciliation of Non-GAAP Financial Measures and Required Reported Data

1

2

3

4

5

6

Reconciliation

($ in millions)

March 31

QTD 2020

QTD 2019

Revenue, Net

$ 240.6

$ 234.0

(+) Deferred revenue adjustment

1.9

0.2

Adjusted revenue

$ 242.5

$ 234.2

Net (loss)

$ (74.0)

$ (59.3)

(-) Provision for income taxes

14.8

0.2

(+) Depreciation and amortization

51.4

58.2

(+) Interest expense, net

30.9

33.1

(+) Transition, Services Agreement costs

1.6

5.3

(+) Transition, transformation and I

2.2

2.5

integration expenses

(+) Deferred revenue adjustment

1.9

0.2

(+) Transaction related costs

26.7

10.3

(+) Stock-based compensation expense

17.5

3.2

(+) Restructuring

7.8

-

(+) Other

(2.6)

5.5

Adjusted EBITDA

$ 78.2

$ 59.2

Descriptions

Adjusted Revenue and Adjusted EBITDA adjustments

  1. In 2020, this is related to a new transition services agreement and offset by the reverse transition services agreement from the sale of MarkMonitor assets. In 2019, this includes payments to Thomson Reuters under the Transition Services Agreement.
  2. Includes costs incurred in connection with and after our separation from Thomson Reuters in 2016 relating to the implementation of our standalone company infrastructure and related cost-savings initiatives. These costs include mainly transition consulting, technology infrastructure, personnel and severance expenses relating to our standalone company infrastructure, which are recorded in Transition, integration, and other line-item of our income statement, as well as expenses related to the restructuring and transformation of our business following our separation from Thomson Reuters in 2016, mainly related to the integration of separate business units into one functional organization and enhancements in our technology.
  3. Reflects the deferred revenues adjustment as a result of purchase accounting.
  4. Includes costs incurred to complete business combination transactions, including acquisitions and dispositions, and typically include advisory, legal and other professional and consulting costs.
  5. Reflects costs incurred in connection with the initiative, following our merger with Churchill Capital Corp in 2019, to streamline our operations by simplifying our organization and focusing on two product groups.
  6. Includes primarily the net impact of foreign exchange gains and losses related to the re- measurement of balances and other items that do not reflect our ongoing operating performance.

20

Reconciliation of Non-GAAP Financial Measures and Required Reported Data

1

2

3

4

5

6

7

8

9

Reconciliation

($ in millions)

Last Twelve Months

March 31, 2020

Net (loss)

$ (225.7)

(-) Provision for income taxes

24.7

(+) Depreciation and amortization

193.8

(+) Interest expense, net

155.5

(+) Transition Services Agreement costs

6.8

(+) Transition, transformation and

24.1

integration expenses

(+) Deferred revenue adjustment

2.2

(+) Transaction related costs

62.6

(+) Stock-based compensation expense

65.7

(+) Restructuring

23.4

(-) Legal Settlement

(39.4)

(+) Impairment on assets held for sale

18.4

(+) Other

0.9

Adjusted EBITDA

$ 313.0

Required reported data

Adjusted EBITDA

$ 313.0

(+) Realized foreign exchange gain

(5.5)

(+) DRG Adjusted EBITDA impact

45.4

(+) Cost savings

44.0

(+) Excess standalone costs

28.5

Standalone adjusted EBITDA

$ 425.4

Descriptions

Adjusted revenue and Adjusted EBITDA adjustments

  1. In 2020, this is related to a new transition services agreement and offset by the reverse transition services agreement from the sale of MarkMonitor assets. In 2019, this includes payments to Thomson Reuters under the Transition Services Agreement.
  2. Includes cash payments in connection with and after our separation from Thomson Reuters in 2016 relating to the implementation of our standalone company infrastructure and related cost-savings initiatives. These cash payments include mainly transition consulting, technology infrastructure, personnel and severance expenses relating to our standalone company infrastructure, which are recorded in Transition, integration, and other line-item of our income statement, as well as cash payments related to the restructuring and transformation of our business following our separation from Thomson Reuters in 2016 mainly related to the integration of separate business units into one functional organization and enhancements in our technology. This also includes cash payments following our merger with Churchill Capital Corp in 2019, to streamline our operations by simplifying our organization and focusing on two product groups.
  3. Reflects the deferred revenues adjustment as a result of purchase accounting.
  4. Includes costs incurred to complete business combination transactions, including acquisitions and dispositions, and typically include advisory, legal and other professional and consulting costs.
  5. Reflects costs incurred in connection with the initiative, following our merger with Churchill Capital Corp in 2019, to streamline our operations by simplifying our organization and focusing on two product groups.
  6. Includes primarily the net impact of foreign exchange gains and losses related to the re-measurement of balances and other items that do not reflect our ongoing operating performance.
  7. Represents DRG Adjusted EBITDA for the period beginning April 1, 2020 until the acquisition date of February 28, 2020 to reflect the company's Standalone EBITDA as though material acquisitions occurred at the beginning of the presented period
  8. Reflects the estimated annualized run-rate cost savings, net of actual cost savings realized, related to restructuring and other cost savings initiatives undertaken during the period (exclusive of any cost reductions in our estimated standalone operating costs).
  9. Reflects the difference between our actual standalone company infrastructure costs, and our estimated

steady state standalone operating costs.

21

Reconciliation of Non-GAAP Financial Measures and Required Reported Data

Reconciliation

($ in millions, except per share amounts)

Net income (loss)

Dilutive impact of potential common shares

Net income (loss)

  1. (+) Transition Services Agreement costs
  2. (+) Transition and integration expenses
  3. (+) Deferred revenue adjustment
  4. (+) Transaction related costs
    1. Stock-basedcompensation expense
    1. Amortization related to acquired intangible assets
  5. (+) Restructuring
    1. Debt extinguishment costs and refinancing related costs
  6. (+) Other

(-) Income tax impact of related adjustments

Adjusted Net income and Adjusted Diluted EPS

Weighted average ordinary shares (Diluted)

March 31

QTD 2020

Amount

Per Share

$ (74.0)

$ (0.22)

  • 0.01

(74.0)(0.20)

1.6-

2.20.01

1.90.01

26.70.07

17.50.05

40.20.11

7.80.02

8.60.02

(2.5)

(0.01)

(4.5)

(0.01)

$ 25.5

$ 0.07

366,584,014

Descriptions

Adjusted Net Income and Adjusted Diluted EPS adjustments

  1. In 2020, this is related to a new transition services agreement and offset by the reverse transition services agreement from the sale of MarkMonitor assets. In 2019, this includes payments to Thomson Reuters under the Transition Services Agreement.
  2. Includes costs incurred in connection with and after our separation from Thomson Reuters in 2016 relating to the implementation of our standalone company infrastructure and related cost-savings initiatives. These costs include mainly transition consulting, technology infrastructure, personnel and severance expenses relating to our standalone company infrastructure, which are recorded in Transition, integration, and other line-item of our income statement, as well as expenses related to the restructuring and transformation of our business following our separation from Thomson Reuters in 2016, mainly related to the integration of separate business units into one functional organization and enhancements in our technology.
  3. Reflects the deferred revenues adjustment as a result of purchase accounting.
  4. Includes costs incurred to complete business combination transactions, including acquisitions and dispositions, and typically include advisory, legal and other professional and consulting costs.
  5. Reflects costs incurred in connection with the initiative, following our merger with Churchill Capital Corp in 2019, to streamline our operations by simplifying our organization and focusing on two product groups.
  6. Includes primarily the net impact of foreign exchange gains and losses related to the re- measurement of balances and other items that do not reflect our ongoing operating performance.

22

Non GAAP Reconciliation - Net Cash Provided By (Used In) Operating Activities to Free Cash Flow and Adjusted Free Cash Flow

Reconciliation

Three Months Ended March 31,

($ in million)

2020

2019

Net cash provided by operating activities

$46.1

$42.5

Capital expenditures

(19.4)

(6.0)

Free cash flow

26.7

36.5

1

Cash paid for transition services agreement

-

12.0

2

Cash paid for transition, transformation and integration expense

20.6

9.4

3

Cash paid for transaction related costs

24.1

5.6

Cash paid for debt issuance costs

7.7

-

Cash received for hedge accounting transactions

(1.2)

-

Adjusted free cash flow

$77.9

$63.5

Descriptions

Free Cash Flow and Adjusted Free Cash Flow Adjustments

  1. Includes cash payments to Thomson Reuters under the Transition Services Agreement. These costs decreased substantially in 2019, as were in the final stages of implementing our standalone company infrastructure. In 2019, the Transition Services Agreement cash paid is offset by cash receipts from the IPM Product Line divestiture.
  2. Includes cash payments in connection with and after our separation from Thomson Reuters in 2016 relating to the implementation of our standalone company infrastructure and related cost-savings initiatives. These cash payments include mainly transition consulting, technology infrastructure, personnel and severance expenses relating to our standalone company infrastructure, which are recorded in Transition, integration, and other line-item of our income statement, as well as cash payments related to the restructuring and transformation of our business following our separation from Thomson Reuters in 2016 mainly related to the integration of separate business units into one functional organization and enhancements in our technology. This also includes cash payments following our merger with Churchill Capital Corp in 2019, to streamline our operations by simplifying our organization and focusing on two product groups.
  3. Includes consulting and accounting costs associated with acquisitions and the sale of MarkMonitor business.

23

Non GAAP Reconciliation - Revenues, Net to Adjusted Revenues

Reconciliation

Year Ending December 31, 2020

(Forecasted)

($ in millions)

Low

High

1 Revenues, net

$

1,130.0

$

1,160.0

Descriptions

Adjusted Revenues, net Adjustments

1. The Company is evaluating the purchase accounting impact, including the deferred revenue adjustment, related to the DRG acquisition.

Non GAAP Reconciliation - Net Income to Adjusted EBITDA

Reconciliation

Year Ending December 31, 2020

(Forecasted)

($ in millions)

Low

High

Net (loss) income

$(70.6)

$(45.6)

Benefit for income taxes

7.8

7.8

Depreciation and amortization

236.9

236.9

1

Interest, net

93.0

93.0

Transition, TSA and integration expenses

46.4

46.4

2

Transaction related costs

50.0

50.0

Share-based compensation expense

30.6

30.6

Other

0.9

0.9

Adjusted EBITDA

$395.0

$420.0

Descriptions

Adjusted EBITDA Adjustments

  1. Includes restructuring costs, other cost optimization activities, and payments and receipts under transition service agreements.
  2. Includes cost associated with merger and acquisition related activities.

Non GAAP Reconciliation -Adjusted EBITDA Margin

Reconciliation

Year Ending December 31, 2020

($ in millions)

(Forecasted)

Low

High

1 Revenues, net

$1,130.0

$1,160.0

Adjusted EBITDA

$395.0

$420.0

Adjusted EBITDA Margin

35%

36%

Descriptions

Adjusted EBITDA Margin Adjustments

1. The Company is evaluating the purchase accounting impact, including the deferred revenue adjustment, related to the DRG acquisition.

24

Non GAAP Reconciliation - Net Loss Per Fully Diluted Weighted Shares Outstanding to Adjusted Diluted EPS

Reconciliation

(in millions, except per share amounts)

Net Income / (Loss)

  1. Transition, TSA and integration expenses
  2. Transaction related costs Share-based compensation
    Amortization related to acquired intangible assets Income tax impact of related adjustments
    Adjusted Net Income and Adjusted Diluted EPS Weighted average common shares (diluted)

Year Ending December 31, 2020

(Forecasted)

Low

High

Per Share

Per Share

$(0.18)

$(0.12)

0.12

0.12

0.13

0.13

0.08

0.08

0.41

0.41

(0.03)

(0.03)

$0.53

$0.59

381,921,495

Descriptions

Adjusted Diluted EPS Adjustments

  1. Includes restructuring costs, other cost optimization activities, and payments and receipts under transition service agreements.
  2. Includes cost associated with merger and acquisition related activities.

Non GAAP Reconciliation - Free Cash Flow and Adjusted Free Cash Flow

Reconciliation

Year Ending December 31, 2020

(Forecasted)

(in millions)

Low

High

Net cash provided by operating activities

$

201.8

$

217.4

Capital expenditures

$

(68.8)

$

(72.4)

Free Cash Flow

$

133.0

$

145.0

1

Transition, transformation and integration expense

$

38.0

$

45.0

2

Transaction related costs

$

49.0

$

50.0

Adjusted Free Cash Flow

$

220.0

$

240.0

Descriptions

Adjusted Free Cash Flow Adjustments

  1. Includes cash payments related to restructuring and other cost optimization activities.
  2. Includes cash payments related to merger and acquisition related activities.

25

Attachments

  • Original document
  • Permalink

Disclaimer

Clarivate Analytics plc published this content on 04 May 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 May 2020 10:08:09 UTC